Page 5 - Lupin Shares News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lupin shares. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lupin Shares Today - Breaking & Trending Today

Lupin announces launch of diagnostics business in India

Lupin also stated that it has established a 45,000 sq ft National Reference Laboratory in Navi Mumbai. ....

Rajeev Sibal , Nilesh Gupta , National Reference Laboratory In Navi Mumbai , Lupin Ltd On , Lupin Ltd , Lupin Diagnostics , National Reference Laboratory , Lupin Healthcare , Lupin Managing Director Nilesh Gupta , India Region Formulations , Upin Diagnostic Centre In India , Upin Tablets , Lupin Shares , Upin Bse ,

rakesh jhunjhunwala: Jhunjhunwala's pharma bet dives after 'optically' good Q1; targets cut

ICICI Securities said Lupins performance was below expectations due to a dip in US sales and lower gross margin. It said US sales would remain under pressure and multiple ongoing USFDA issues would weigh on new approvals. ....

United States , Rakesh Jhunjhunwala , Boehringer Ingelheim , Institutional Equities , North American , Oswal Securities , Jm Financial , Analyst Stock Targets , Usfda Oia , Icici Securities , Lupin Shares , ஒன்றுபட்டது மாநிலங்களில் , ராகேஷ் ஜுன்ஜுன்வாலா , போஹெரிங்கர் இஂகல்‌ஹைம் , நிறுவன பங்குகள் , வடக்கு அமெரிக்கன் , ஒசுவள் பத்திரங்கள் , ஜ்ம் நிதி , இஸிசீ பத்திரங்கள் , லூபின் பங்குகள் ,

Jhunjhunwala's biggest pharma bet defies doomsayers, surpasses four-year high

Trading volume on the counter was almost three times higher than its two-week average trading volume on BSE. Over 5.25 million shares changed hands till 1.15 pm on both BSE and NSE. ....

Rakesh Jhunjhunwala , Tata Motors , Titan Company , Investors Rakesh Jhunjhunwala , Yes Securities , Rakesh Jhunjhunwala Bets , Lupin Shares , Pharma Stock , Consolidated Sales , Big Bull Bets , Brokerages View , ராகேஷ் ஜுன்ஜுன்வாலா , டாடா மோட்டார்கள் , டைட்டன் நிறுவனம் , ஆம் பத்திரங்கள் , ராகேஷ் ஜுன்ஜுன்வாலா சவால் , லூபின் பங்குகள் , பார்மா ஸ்டாக் , தொகுக்கப்பட்டு விற்பனை ,

Rakesh Jhunjhunwala's pharma bet hits new 52-week high; should you buy?

According to the shareholding pattern for March 2021, Rakesh Jhunjhunwala held 1.6 per cent stake or 72,45,605 Lupin shares at the end of Q4. ....

Rakesh Jhunjhunwala , Rakesh Jhunhjhunwala , Motilal Oswal , Nilesh Gupta , Boehringer Ingelheim , Biologics License Application , Lupin Shares , Lupin Stock , 52 Week High , Four Year High , Upin View , Jhunjhunwala Portfolio , ராகேஷ் ஜுன்ஜுன்வாலா , மோட்டிலால் ஒசுவள் , நிலேஷ் குப்தா , போஹெரிங்கர் இஂகல்‌ஹைம் , உயிரியல் உரிமம் விண்ணப்பம் ,

Brokerages raise target price on Lupin by up to 50%

Brokerages raise target price on Lupin by up to 50%
CLSA retained a ‘sell’ rating saying that the key positives are more than priced in at 27 times FY23 price to earnings.
Synopsis
Progress on other respiratory assets, biosimilars and resolution of warning letters will enhance medium-term growth visibility, said Kotak Institutional.
Mumbai: Brokerages have raised target price on Lupin by 9-50% after the company on Thursday reported an 18% increase in its consolidated net profit for the March quarter. Shares of Lupin ended down 2.6% at ₹1,178.80 on Friday.
Kotak Institutional Equities said Lupin is well positioned to deliver strong margin expansion over FY22-23. Progress on other respiratory assets, biosimilars and resolution of warning letters will enhance medium-term ....

Kotak Institutional Equities , Us Food And Drug Administration , Lupin Shares , Kotak Institutional , Icici Securities , கோட்டக் நிறுவன பங்குகள் , லூபின் பங்குகள் , கோட்டக் நிறுவன , இஸிசீ பத்திரங்கள் ,